Notably, preclinical studies have shown the concept that targeting both EZH1 and EZH2 can normalize the accumulation of H3K27me3 not only in high-grade tumor cells but also in cells in a precancerous state infected with HTLV-1 present in the peripheral blood of infected individuals [28] (Figure 1C). Here, EZH2 is linked to neoplasm.